Seres Therapeutics, Inc. (NASDAQ:MCRB) Sees Large Decrease in Short Interest
MarketBeat
Seres Therapeutics, Inc. (NASDAQ:MCRB - Get Free Report) was the target of a significant decline in short interest in the month of April. As of April 15th, there was short interest totalling 763,100 shares, a decline of 95.2% from the March 31st total of 16,010,000 shares. Based on an average daily volume of 70,300 shares, the short-interest ratio is currently 10.9 days. Approximately 12.0% of the shares of the company are sold short.
NASDAQ:MCRB